Light technical assessment
IT Manager roles focus more on architecture understanding than hands-on coding. Expect high-level system discussions and technical problem-solving scenarios.
0 roles from funded startups and hidden sources. Posted
minutes ago. Updated every 60 seconds
Focus areas that matter most for senior IT leadership positions. Explore key insights and preparation tips to help you excel in your interview process.
IT Manager roles focus more on architecture understanding than hands-on coding. Expect high-level system discussions and technical problem-solving scenarios.
Design enterprise IT systems, discuss scalability, security, and vendor management strategies.
Enterprise Architecture
Design scalable IT infrastructure
Security Frameworks
Implement security protocols
Vendor Management
Technology stack decisions
Companies evaluate IT management experience, team leadership, and strategic technology planning.
Fortune 500
Enterprise transformation and compliance
Tech Startups
Rapid scaling and technology decisions
Compare cost-of-living buying power and how crowded the market is versus other major tech cities—so you can focus your search where the odds fit your goals.
Baltimore offers IT Managers approximately 65% lower housing costs and 60% lower overall living expenses compared to San Francisco, enabling significantly higher disposable income and homeownership opportunities while maintaining competitive tech salaries in the $95K-$140K range.
Baltimore's IT Manager market shows lower saturation than major tech hubs, creating better opportunities for career advancement and competitive positioning.

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job postsPearl Diagnostics is a Baltimore-based biotech spun out of Johns Hopkins University in 2014 that builds non-invasive urine-based diagnostic tests for lung infections. Its flagship MycoMEIA Aspergillus urine assay, which received FDA 510(k) clearance in August 2025 and CE approval for the EU, replaces invasive bronchoalveolar lavage procedures used to detect aspergillosis in transplant recipients, cancer patients, and immunocompromised individuals. The company is extending the same antigen-detection platform to other fungal and bacterial pathogens, including a Pseudomonas assay for cystic fibrosis patients.
Raised
$11.2M
Series A · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Baltimore, Maryland
United States